Uncategorized Archives - Page 1015 of 1028

WednesdaySep 07, 2016 8:52 am

Stratasys (SSYS) PolyJet 3D Printing Platform Forms Basis for Launch of Promolding’s Printed Injection Molding Division

Stratasys Ltd. (NASDAQ: SSYS), a world leader in 3D printing, announced on Friday, September 2, 2016, that Promolding, a Netherlands-based global design, engineering and manufacturing firm, will be introducing a 3D PRinted Injection Molding Division (PRIM) employing the company’s PolyJet 3D printing solutions. This approach to the production of molds is expected to reduce injection mold lead-times for Promolding customers by 93 percent. In the news release, Jeroen Gross, product development manager at Promolding, explained why his company chose Stratasys’ printing solutions: “We became increasingly aware of the need for a 3D printer that would help us optimize our product…

WednesdaySep 07, 2016 8:24 am

OBI Pharma, Inc. to Present its Flagship Immunotherapy at Annual European Society for Medical Oncology Meeting

OBI Pharma, Inc., a Taiwan biotech developing therapeutic agents and next-gen active immunotherapies for a range of unmet medical needs and indications, is scheduled to host an industry-sponsored satellite symposium at the 2016 European Society for Medical Oncology (ESMO) Annual Meeting taking place in Copenhagen, Denmark, next month. The symposium, titled "Novel Approaches to Active Immunotherapy in Oncology – Targeting Globo Series with Adagloxad Simolenin," will review data on targeting Globo Series antigens in metastatic breast cancer and other cancers with OBI Pharma’s investigational active immunotherapy, Adagloxad Simolenin (formerly OBI-822), and will examine the future of active immunotherapy in oncology.…

TuesdaySep 06, 2016 11:35 am

Sully Discovery by Star Mountain Resources, Inc. (SMRS) Confirms Richness of Balmat Mine Host Rock

The announcement by Star Mountain Resources, Inc. (OTC: SMRS) of the Sully discovery validates the company’s decision to reactivate the Balmat mine. The company’s recently completed district-wide review and evaluation, which targeted zinc mineralization in the Balmat-Edwards Mining District of St. Lawrence County, New York, yielded encouraging results. The review identified significant potential zinc mineralization, labeled the ‘Sully discovery’, in the Upper Marble unit at a location approximately one mile southwest of the historic Hyatt Mine and four miles northeast of the Balmat mine. The Upper Marble unit contains the rock within which the ore deposit occurs, known as host…

TuesdaySep 06, 2016 8:53 am

Moxian, Inc. (MOXC) Helping Merchants Target the Right Audiences with Intelligent Data Analytics

When it comes to social media advertising, there are a number of insights into the best way of reaching the right audience. Most experts will start by establishing a budget, choosing the right channels through which to advertise, and creating ads that they hope will kick off the process of converting viewers to customers. Smart ads are not just posted to random audiences, but rather are tailored to reach the person that fits the criteria specified for that particular ad. WordStream (http://nnw.fm/9jAUu) emphasizes that “Targeting all of your fans isn’t precise. It’s lazy and you’ll waste a lot of money.…

FridaySep 02, 2016 3:59 pm

Development of CorMedix, Inc.’s (CRMD) Bloodstream Infection Therapy on Pace for Regulatory Approval

Catheter-related bloodstream infections (CRBSIs) are one of the most frequently encountered types of infections contracted in hospital units, resulting in billions of dollars in additional expenses for the U.S. healthcare system every year. It is estimated that there are roughly 250,000 CRBSIs every year, a third of them reported in ICUs. These infections lead to increased hospital stays and higher care costs ranging from approximately $4,000 to $56,000. Additionally, CRBSI cases have an attributable mortality rate of 12% to 25%. CorMedix Inc. (NYSE: CRMD), a biopharmaceutical company that focuses on developing treatments for infections and inflammatory diseases, is developing a…

FridaySep 02, 2016 3:00 pm

Will ADDvantage Technologies Group, Inc. (AEY) Repeat its CATV Success in Telco?

ADDvantage Technologies Group, Inc. (NASDAQ:AEY) has earned a reputation as a one-stop-shop in the cable TV (CATV) industry. The company, based in Broken Arrow, Oklahoma, has made a name for itself selling and servicing new, surplus and refurbished cable television equipment to CATV operators. Many of its customers are multiple system operators (MSOs) of CATV franchises and other large outfits that sell to these customers. And although mainly concentrated in the domestic market, the company has customers in Canada, Central America, South America and throughout the world. However, current trends in CATV are like the fare to be seen on…

FridaySep 02, 2016 11:28 am

Nemaska Lithium, Inc. (NMKEF) Positioned to Become Lithium Hydroxide and Lithium Carbonate Supplier

According to the “Global Lithium Market Outlook” report put together by Goldman Sachs HCID Conference (http://nnw.fm/M0wCq), there are a number of trends driving lithium growth. One of the key reasons lithium has not plummeted like some commodities is the continued growth of electrical devices across the world and the high power they require from lithium-based power units. Lithium is, of course, increasingly used in a number of mobile energy systems, including EVs, producing greater energy with less weight and fewer chemicals. But lithium is also an active pharmaceutical and agro ingredient, and in other applications. According to the report, the…

FridaySep 02, 2016 10:43 am

Orexigen Therapeutics, Inc. (OREX) Announces Valeant Canada will Commercialize Contrave®

Orexigen Therapeutics, Inc. (NASDAQ: OREX) recently announced a distribution agreement between its Orexigen Therapeutics Ireland Ltd. subsidiary and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) regarding the commercialization and distribution of Contrave® (naltrexone HCl / bupropion HCl extended release) in Canada. Per the agreement, Valeant Canada, a subsidiary of Valeant Pharmaceuticals, will be responsible for obtaining Canadian regulatory approval for all the commercialization activities and expenditures. Orexigen will supply Valeant Canada with Contrave tablets at an agreed price, along with potential sales and milestone payments, and expects Valeant to file for Canadian regulatory approval by January 2017. CEO of Orexigen, Mike…

ThursdaySep 01, 2016 5:27 pm

Garmin Ltd. (GRMN) Poised for Strong Position in Navigation, Wearables & Avionics with $200M Expansion Plans

Garmin (NASDAQ: GRMN), which handsomely outperformed analyst estimates by nearly 30 percent with Q2 EPS of $0.87 in July (6.4 percent higher revenues than the consensus), has evolved into one of the most compelling homegrown success stories of the modern age. Able to strike hard and fast across a slew of global markets with an impressive portfolio of GPS-enabled navigation and VHF (very high frequency) solutions, the Kansas-based device maker is known for its navigation products, is a veritable institution in the Kansas City metro area, and has also become a major player in the nearly $29 billion wearables space.…

ThursdaySep 01, 2016 4:57 pm

Ericsson (ERIC) and Cisco (CSCO) Partner with C&W Communications to Supply Caribbean IP Networks

Ericsson (NASDAQ: ERIC) and Cisco (NASDAQ: CSCO) have partnered with Cable & Wireless Communications plc (C&W) to supply IP networks in three Caribbean markets. Under the agreement, Cisco will provide the hardware and Ericsson will offer project management services for C&W’s investment plan for the region, which includes an IP backbone network upgrade in the Bahamas to support higher traffic and improved performance, as well as the installation of a new B2B IP/MPLS network in Barbados and Jamaica. "We needed a powerful and intelligent solution to bring IP networking to both Jamaica and Barbados, while at the same time improving…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Uncategorized